Furthermore, Gamperl et al. found that tinzaparin (a low-molecular-weight heparin) induced tissue factor pathway inhibitor (TFPI) release from tumor cells, and recombinant TFPI inhibited tumor exosomes induced tumor cell migration [54]. This evidence concerns the gene TFPI and neoplasm.